Healthcare Services

Biologics Testing Market Forecast 2026–2035 Highlighting Market Data Patterns and Industry Insights

March 30, 2026March 30, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Biologics Testing Market Over The 2026–2030 Period?

The biologics testing market has experienced significant growth in recent years. Its value is projected to expand from $6.83 billion in 2025 to $7.99 billion in 2026, reflecting a compound annual growth rate (CAGR) of 17.0%. Historically, this growth has been driven by increased biologics manufacturing volumes, the expansion of vaccine development programs, heightened regulatory expectations regarding product safety, broader adoption of monoclonal antibody therapies, and the proliferation of contract testing laboratories.

The biologics testing market size is anticipated to undergo significant growth in the coming years. It is projected to expand to $15.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 17.2%. This expansion during the forecast period is driven by a heightened demand for rapid release testing, the increasing integration of automated quality control systems, the broadening scope of cell and gene therapy testing requirements, a stronger emphasis on data integrity, and increasing investments in digital laboratory infrastructure. Prominent trends observed during the forecast period encompass the wider adoption of advanced analytical testing platforms, a surging requirement for comprehensive biologics quality testing, the expanding utilization of high-sensitivity assays, the proliferation of outsourced testing services, and an intensified focus on regulatory compliance testing.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10276&type=smp

Which Economic Or Industry Drivers Are Impacting The Biologics Testing Market?

The expanding pharmaceutical and biotechnology sectors are projected to fuel the advancement of the biologics testing market in the future. The pharmaceutical industry primarily concentrates on creating and producing medicines for diverse ailments and health issues. Conversely, the biotechnology industry centers on applying technology to biological sciences and healthcare. Biologics testing encompasses examinations to pinpoint and measure impurities, determine stability, and gauge the immune reaction to a therapeutic agent. The expansion of these industries has also spurred progress in biologics testing technology, for instance, through the creation of novel analytical instruments and methods. This development has enabled more precise and streamlined testing, thereby lowering the duration and expense involved in launching new biologics. For example, data from July 2024, provided by Eurostat, a governing organization situated in Belgium, indicated that pharmaceutical output in the EU reached €44 billion ($46.7 billion) in 2023, signifying substantial expansion within the industry. Consequently, the swift expansion of the pharmaceutical and biotechnology industries is a key factor propelling the biologics testing market forward.

How Is The Biologics Testing Market Segmented Across Key Categories?

The biologics testing market covered in this report is segmented –

1) By Product: Reagents And Kits, Instruments, Other Products

2) By Test Type: Endotoxin Test, Sterility Test, Mycoplasma Tests, Bioburden Tests, Residual Host-Cell Proteins And DNA Detection Tests, Virus Safety Test, Other Test Types

3) By Application: Vaccine Development And Manufacturing, Monoclonal Antibodies Development And Manufacturing, Cellular And Gene Therapy Products Development And Manufacturing, Blood And Blood Products Development And Manufacturing, Other Applications

Subsegments:

1) By Reagents And Kits: ELISA Kits, PCR Kits, Cell Culture Reagents

2) By Instruments: Spectrophotometers, Chromatography Systems, Microplate Readers

3) By Other Products: Software, Consumables, Reference Standards

What Key Trends Are Influencing The Development Of The Biologics Testing Market?

Key companies operating within the biological testing market are introducing novel technologies, such as protein engineering techniques, to elevate their profitability. Protein engineering pertains to the intentional design and modification of proteins to yield new or enhanced variants possessing desired attributes. For instance, in July 2023, Queensland University of Technology, an Australia-based university, unveiled an innovative protein-engineering method that facilitates the rapid and precise creation of new diagnostic tests. This technology presents a fresh approach for refining and broadening laboratory testing capabilities, promising a substantial positive influence on both public health and the economy.

Who Are The Dominant Players Shaping The Biologics Testing Market Landscape?

Major companies operating in the biologics testing market are Charles River Laboratories Inc., Thermo Fisher Scientific Inc., Merck KGaA, SGS Société Générale de Surveillance SA, WuXi AppTec Co. Ltd., Sartorius AG, Cytovance Biologics Inc., Pace Analytical Services Inc., Avance Biosciences Inc., Biomerieux SA, Lonza Group Ltd., Genscript Biotech Corp., Bio-Rad Laboratories Inc., Accugen Laboratories Inc., Gibraltar Laboratories Inc., Jordi Labs, Bioquell Limited, Southern Research, Promega Corporation, Lancaster Laboratories Inc., Toxikon Corporation, Eurofins BioPharma Product Testing, QIAGEN N.V., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., Abbott Laboratories, Beckman Coulter Inc., Becton Dickinson and Company, Roche Holding AG

Read the full biologics testing market report here:

https://www.thebusinessresearchcompany.com/report/biologics-testing-global-market-report

What Are The Top-Performing Regions Within The Biologics Testing Market?

North America was the largest region in the biologics testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global biologics testing market duirng the forecast period. The regions covered in the biologics testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Biologics Testing Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10276&type=smp

Browse Through More Reports Similar to the Global Biologics Testing Market 2026, By The Business Research Company

Biologics Contract Development Global Market Report

https://www.thebusinessresearchcompany.com/report/biologics-contract-development-global-market-report

Veterinary Biologics Global Market Report

https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report

Biologics Cdmo Global Market Report

https://www.thebusinessresearchcompany.com/report/biologics-cdmo-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795